Follow-The-Filings

Security · featured owners

TEVA

Teva Pharmaceutical Inds Ltd SPONSORED ADS Equity as of 2026 Q2 among managers we track

  • 8 Owners
  • #170
  • Max 4.0%
  • Master 0.02%
  • $340M
  • 1 new 2 add 5 reduce

Who owns this now

Largest portfolio weights among featured holders · max 4.0% (Harry Burn - Sound Shore ...) · not free-float ownership

all holders →
  1. Harry Burn reduce 4.0%
  2. Glenview Capital Management reduce 3.1%
  3. David Witzke reduce 1.1%
  4. Stanley Druckenmiller reduce 0.4%
  5. David Einhorn new 0.1%
  6. Cathie Wood add 0.02%

holders

sorted by % of portfolio · long equity only · open a manager for their book

history
Harry Burn - Sound Shore Management Inc. /CT/ 2026 Q2 4.0% Reduce −2.1% 3,804,497 $129M hist
Glenview Capital Management 2026 Q2 3.1% Reduce −23.7% 5,081,091 $172M hist
David Witzke - Avidity Partners Management 2026 Q2 1.1% Reduce −55.6% 200,000 $7M hist
Stanley Druckenmiller - Duquesne Family Office 2026 Q2 0.4% Reduce −73.7% 624,999 $21M hist
David Einhorn - Greenlight Capital 2023 Q4 stale 0.1% New 0.1% 268,470 $3M hist
Cathie Wood - Ark Investment Management 2026 Q2 0.02% Add +0.5% 68,653 $2M hist
Ron Baron - Bamco Inc. /NY/ (Baron Capital) 2026 Q2 0.01% Add +6.9% 138,987 $5M hist
Farallon Capital Management 2026 Q2 0.01% Reduce −88.7% 40,000 $1M hist

8 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $15.85B $16.54B $17.26B
Gross profit $7.64B $8.06B $8.94B
Gross margin * 48.2% 48.7% 51.8%
Net income -$220M -$1.64B $1.41B
Net margin * -1.4% -9.9% 8.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $12.48B $12.55B $13.95B
Total non-current assets * $30.98B $26.77B $26.8B
Total assets $43.46B $39.33B $40.75B
Total current liabilities $12.25B $12.8B $13.46B
Total non-current liabilities $24.55B $20.81B $19.38B
Total equity $7.51B $5.37B $7.91B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.37B $1.25B $1.65B
Cash from investing $968M $792M $737M
Cash from financing -$1.91B -$1.79B -$2.15B
Net change in cash $393M $74M $256M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders